Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SLS

SELLAS Life Sciences Group Inc

Jun 18 • 04:00PM ET

8.05

+0.29 3.74 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: IDYA TNGX CGON RCUS NUVL BMRN KYMR RYTM INCY KRYS

| Held by: VTI XBI IWM VXF IWO VTWO VHT IWC PTH VFMO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.23	Insider Own	0.43%	Shs Outstand	186.03M	Perf Week	3.87%
Market Cap	1.50B	Forward P/E	-	EPS next Y	-0.15	Insider Trans	0.00%	Shs Float	185.24M	Perf Month	6.06%
Enterprise Value	1.39B	PEG	-	EPS next Q	-0.05	Inst Own	29.17%	Short Float	32.93%	Perf Quarter	54.81%
Income	-29.46M	P/S	-	EPS this Y	16.00%	Inst Trans	9.94%	Short Ratio	7.92	Perf Half Y	265.91%
Sales	0.00M	P/B	13.59	EPS next Y	28.57%	ROA	-39.50%	Short Interest	61.00M	Perf YTD	113.53%
Book/sh	0.59	P/C	13.97	EPS next 5Y	50.68%	ROE	-43.58%	52W High	9.51 -15.35%	Perf Year	412.74%
Cash/sh	0.58	P/FCF	-	EPS past 3/5Y	51.28% 34.92%	ROIC	-27.35%	52W Low	1.39 479.14%	Perf 3Y	409.49%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.04% 10.16%	Perf 5Y	-29.32%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	41.60%	Oper. Margin	-	ATR (14)	0.69	Perf 10Y	-99.99%
Dividend Ex-Date	Mar 24, 2011	Quick Ratio	17.22	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	55.27	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	17.22	EPS Q/Q	26.44%	SMA20	-1.14%	Beta	2.56	Target Price	10.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	23.51%	Rel Volume	1.91	Prev Close	7.76
Employees	13	LT Debt/Eq	0.00	Earnings	May 12 AMC	SMA200	106.42%	Avg Volume	7.70M	Price	8.05
IPO	Mar 12, 2008	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.67% -	Trades		Volume	14,686,537	Change	3.74%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)